Sinopharm Holdings (01099) issued an announcement. Sinopharm Group, a subsidiary of the company, is united Pharmaceutical Co., Ltd. (Sinopharm 1...
Zhitong Finance App News, Sinopharm Holdings (01099) announced that the company's subsidiary Sinopharm Group Pharmaceutical Co., Ltd. (000028.SZ) achieved operating income of 75.477 billion yuan, an increase of 2.77% year on year ended December 31, 2023; net profit attributable to shareholders of listed companies was 1,599 billion yuan, up 7.57% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 1,533 billion yuan, up 7.58% year on year; basic earnings per share were 2.87 yuan/share.